Clinical Trials › NCT05811416
Active, Not Recruiting
A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
Sponsored by Bristol-Myers Squibb
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 200
Target enrollment
Jun 2023
Start date
Nov 2026
Expected completion
Conditions studied
Relapsing-remitting Multiple Sclerosis (RRMS)
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
